Ciąża ektopowa – Rokowania, prognozy i postęp choroby

Ciąża ektopowa
Rokowania, prognozy i postęp choroby

Ciąża ektopowa jest główną przyczyną śmiertelności kobiet w pierwszym trymestrze, odpowiadając za 9-14% zgonów związanych z ciążą. Wczesne rozpoznanie i szybka interwencja, zarówno farmakologiczna (metotreksat) jak i chirurgiczna (salpingotomia lub salpingektomia), znacząco zmniejszają ryzyko powikłań, takich jak pęknięcie jajowodu i krwotok zagrażający życiu. Skuteczność leczenia metotreksatem wynosi 88,1% przy jednorazowej dawce i 92,7% przy schemacie wielodawkowym, z medianą czasu do rozwiązania ciąży ektopowej około 22 dni, zależną od wyjściowego poziomu hCG (szczególnie powyżej 2000 IU/L). Spadek stężenia hCG o 15% między 4 a 7 dniem leczenia jest silnym wskaźnikiem powodzenia terapii, a wczesne monitorowanie zmian hCG (dni 0-4) dostarcza wartości prognostycznych z prawdopodobieństwem sukcesu leczenia do 85% przy hCG ≤3000 IU/L. W przypadku ciąż o nieznanej lokalizacji (PUL) stosunek hCG jest preferowanym markerem prognostycznym, przewyższającym pojedyncze pomiary progesteronu, który natomiast skutecznie wyklucza żywotną ciążę przy stężeniach poniżej 3,2-6 ng/ml, ale nie różnicuje ciąży ektopowej od innych stanów.

Prognoza w ciąży ektopowej (Ciąża ektopowa – Prognoza)

Czynniki wpływające na rokowanie
Prognoza płodności po ciąży ektopowej
Skuteczność leczenia farmakologicznego
Czas do rozwiązania ciąży ektopowej
Wczesne prognostyki skuteczności leczenia
Prognostyki w ciąży o nieznanej lokalizacji
Rola progesteronu w prognozowaniu
Znaczenie wsparcia psychologicznego
Wnioski końcowe
Kolejne rozdziały

Prognoza w ciąży ektopowej (Ciąża ektopowa – Prognoza)

Ciąża ektopowa stanowi główną przyczynę śmiertelności kobiet w pierwszym trymestrze ciąży, odpowiadając za 9-14% wszystkich zgonów związanych z ciążą, z częstością występowania wynoszącą 5-10% wszystkich zgonów związanych z ciążą.¹² Rokowanie w ciąży ektopowej zależy przede wszystkim od wczesnego rozpoznania i szybkiej interwencji. W przypadku wczesnego zdiagnozowania i leczenia przed pęknięciem jajowodu, czy to metodą farmakologiczną z zastosowaniem metotreksatu, czy chirurgiczną, ryzyko poważnych powikłań jest znacznie zmniejszone.³

Czynniki wpływające na rokowanie

Opóźniona diagnoza może prowadzić do pęknięcia jajowodu, powodując zagrażający życiu krwotok i niestabilność hemodynamiczną. W takich przypadkach konieczna jest natychmiastowa interwencja chirurgiczna, która może obejmować salpingektomię (usunięcie jajowodu), co potencjalnie wpływa na przyszłą płodność.⁴ Pacjentki z historią ciąży ektopowej są narażone na zwiększone ryzyko nawrotu, szczególnie jeśli występują czynniki ryzyka, takie jak wcześniejsza operacja jajowodu, choroba zapalna miednicy lub zastosowanie technik wspomaganego rozrodu.⁵

Szanse na pomyślne zakończenie ciąży po przebytej ciąży ektopowej zależą od kilku czynników:⁶

Wieku kobiety
Wcześniejszego posiadania dzieci
Przyczyny pierwszej ciąży ektopowej
Stanu zdrowia jajowodów

Prognoza płodności po ciąży ektopowej

Przyszła płodność jest istotnym czynnikiem, który należy wziąć pod uwagę podczas leczenia ciąży ektopowej. Badania, takie jak badanie DEMETER, wykazały brak istotnej różnicy w wskaźnikach płodności po leczeniu farmakologicznym i zachowawczym leczeniu chirurgicznym.⁷ Badanie ESEP również wykazało, że salpingotomia (nacięcie jajowodu) i salpingektomia (usunięcie jajowodu) nie wpływają znacząco na wyniki przyszłych ciąż.⁸

Około jedna na trzy kobiety, które miały ciążę ektopową, może w przyszłości urodzić dziecko. Jednak ryzyko kolejnej ciąży ektopowej jest zwiększone, a niektóre kobiety nie zachodzą ponownie w ciążę.⁹ Wcześniejszy wywiad niepłodności okazał się najbardziej istotnym czynnikiem wpływającym na płodność po zabiegu chirurgicznym.¹⁰

Współczesny chirurg miednicy jest przekonany, że metodą z wyboru w leczeniu niepękniętej ciąży ektopowej jest salpingotomia, oszczędzająca zajęty jajowód i tym samym poprawiająca przyszłe wyniki reprodukcyjne.¹¹ Jednakże, dane z literatury nie wykazały istotnych i spójnych korzyści zarówno z salpingostomii, jak i salpingektomii w zakresie poprawy przyszłych wyników reprodukcyjnych.¹² Mimo ryzyka przetrwałej ciąży ektopowej, niektóre badania wykazały, że salpingostomia poprawia wyniki reprodukcyjne u pacjentek z uszkodzeniem drugiego jajowodu.¹³

Skuteczność leczenia farmakologicznego

Wskaźniki powodzenia po zastosowaniu metotreksatu są porównywalne z laparoskopową salpingostomią, przy założeniu, że przestrzegane są wcześniej wspomniane kryteria kwalifikacji.¹⁴ Średnie wskaźniki powodzenia przy zastosowaniu schematu wielodawkowego mieszczą się w zakresie 91-95%, co wykazało wielu badaczy.¹⁵ Meta-analiza obejmująca dane z 26 badań wykazała wskaźnik powodzenia 88,1% w przypadku schematu z jednorazową dawką metotreksatu i 92,7% w przypadku schematu wielodawkowego.¹⁶

Czas do rozwiązania ciąży ektopowej

Mediana czasu do rozwiązania ciąży ektopowej leczonej metotreksatem wynosi 22 dni i jest związana z wyjściowym poziomem hCG. Wartość predykcyjna wyjściowego poziomu hCG może być przydatna w podejmowaniu decyzji klinicznych i poradnictwie dla kobiet rozważających leczenie ciąży ektopowej metotreksatem.¹⁷ Czas do rozwiązania był dłuższy, gdy wyjściowe stężenie hCG przekraczało 2000 IU/L, a wczesne trendy w poziomie hCG były predykcyjne dla czasu do rozwiązania i powodzenia leczenia.¹⁸

Badanie wykazało, że poziomy wyjściowe hCG były związane z czasem do rozwiązania, ze wzrostem z 20 dni, gdy poziomy wyjściowe hCG wynosiły 1000 IU/L, do 34,5 dni dla poziomów 2000-2999 IU/L.¹⁹ Duży wzrost hCG do 4 dnia o wartości do 999 IU/L był związany ze znacznym wydłużeniem czasu do rozwiązania (21 vs 61 dni) i prawdopodobieństwem konieczności zastosowania ratunkowego zabiegu chirurgicznego (iloraz szans 28,6).²⁰

Wczesne prognostyki skuteczności leczenia

Obecną miarą skuteczności leczenia ciąży ektopowej jednorazową dawką metotreksatu jest spadek stężenia hCG w surowicy o 15% między 4 a 7 dniem leczenia, który ma dodatnią wartość predykcyjną 93% dla powodzenia leczenia.²¹ Dwa małe badania zaproponowały, że spadek stężenia hCG w surowicy między dniem 0 a 4 po leczeniu daje podobne, wcześniejsze informacje prognostyczne, z dodatnimi wartościami predykcyjnymi 100% i 88% dla powodzenia leczenia.²²

Potwierdzono, że spadek stężenia hCG w surowicy między dniem 0 a 4 po leczeniu metotreksatem ciąży ektopowej, z wyjściowym stężeniem hCG w surowicy ≤3000 IU/L, dostarcza wczesnego wskazania na prawdopodobieństwo powodzenia leczenia i działa równie dobrze jak istniejąca miara, która dostarcza informacji prognostycznych dopiero w dniu 7.²³

Badanie wykazało, że spadek stężenia hCG w surowicy między dniem 0 a 4 leczenia oznacza 85% prawdopodobieństwo powodzenia leczenia bez dalszej interwencji, medycznej lub chirurgicznej, w przypadku leczenia ciąży ektopowej jednorazową dawką metotreksatu.²⁴

Prognostyki w ciąży o nieznanej lokalizacji

W przypadku ciąży o nieznanej lokalizacji (PUL – Pregnancy of Unknown Location), stosunek hCG (hCG ratio) wydaje się być optymalnym testem do przewidywania niepowodzenia ciąży.²⁵ Najważniejszą zmienną dla przewidywania prawdopodobieństwa powodzenia niechirurgicznego leczenia był przedleczniczy stosunek hCG.²⁶

Model regresji logistycznej, oparty na stosunku hCG, może być wykorzystany do przewidywania wyniku ciąż o nieznanej lokalizacji, szczególnie ciąż ektopowych, z wysokim stopniem pewności.²⁷ Stosunek hCG może być preferowany w stosunku do pojedynczych pomiarów progesteronu w prognozowaniu żywotności wewnątrzmacicznych ciąż o niepewnej żywotności w populacji PUL.²⁸

Rola progesteronu w prognozowaniu

Pojedynczy pomiar progesteronu u kobiet we wczesnej ciąży z krwawieniem lub bólem i niejednoznacznymi ocenami ultrasonograficznymi może wykluczyć żywotną ciążę. Meta-analiza wykazała, że niskie stężenie progesteronu (mniej niż 3,2 do 6 ng/ml) u tych kobiet wykluczyło żywotną ciążę w 99,2% przypadków.²⁹ Jednak test ten nie może odróżnić kobiet z ciążą ektopową od tych z wczesną normalną ciążą lub poronieniem i nie powinien być stosowany w tym celu.³⁰

Istniejące dowody pokazują, że swoistość jest wyższa (98,4%), a czułość niższa (74,6%) przy zastosowaniu wartości granicznej około 5 ng/ml.³¹ Test ten może być dodany do istniejących algorytmów oceny wczesnej ciąży, a jego efekt powinien być oceniony poprzez randomizowane badanie porównujące algorytmy z i bez stężenia progesteronu w surowicy.³²

Znaczenie wsparcia psychologicznego

Zarządzanie psychologiczne jest kluczowym czynnikiem wpływającym na pomyślne wyniki po diagnozie i leczeniu ciąży ektopowej.³³ Ogólnie rzecz biorąc, przy odpowiednim zarządzaniu, większość pacjentek dobrze się regeneruje, ale długoterminowa obserwacja jest ważna, aby rozwiązać problemy związane z płodnością i monitorować potencjalne nawroty.³⁴

Wnioski końcowe

Jeśli ciąża ektopowa zostanie wcześnie zdiagnozowana, leczenie jest bardzo skuteczne. Ważne jest, aby szukać wczesnej opieki, gdy tylko podejrzewa się ciążę, aby lekarz mógł określić lokalizację ciąży.³⁵ Innowacje w zarządzaniu ciążą ektopową mają na celu zachowanie płodności i obejmują laparoskopową częściową resekcję jajowodu z zespoleniem koniec do końca i embolizację tętnicy macicznej z wewnątrzmacicznym wlewem metotreksatu.³⁶

Pomimo potencjalnych zagrożeń związanych z ciążą ektopową, wczesne rozpoznanie i odpowiednie leczenie znacznie poprawiają rokowanie. Praktycznie wszystkie ciąże ektopowe są uważane za nieżywotne i istnieje ryzyko ewentualnego pęknięcia i związanego z tym krwotoku. Poza bezpośrednią chorobowością spowodowaną ciążą ektopową, również przyszła zdolność kobiety do reprodukcji może być niekorzystnie zmieniona. Jednak pacjentki, u których ciąża ektopowa jest zdiagnozowana przed pęknięciem, mają niską śmiertelność i również szansę na zachowanie płodności.³⁷

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

Materiały źródłowe

#1
https://pmc.ncbi.nlm.nih.gov/articles/PMC10071153/
Ectopic pregnancies are the leading cause of maternal mortality in the first trimester, with an incidence of 5%10% of all pregnancy-related deaths. […] Ectopic pregnancy (EP) ruptures are the leading cause of maternal mortality within the first trimester of pregnancy with a rate of 9%14% and an incidence of 5%10% of all pregnancy-related deaths. […] The current standard for diagnostics includes ultrasound (US) imagingtransvaginal (TVUS) or transabdominal (TAUS)and -human chorionic gonadotropin (-hCG) level monitoring. Earlier and more specific EP diagnosis can help reduce maternal mortality rates. […] Once an EP is diagnosed, treatment can consist of medical, surgical, or expectant management, with innovative emphasis on conservation of fertility. […] Current innovations in ectopic pregnancy management aim to preserve fertility and include laparoscopic partial tubal resection with end-to-end anastomosis and uterine artery embolization with intrauterine infusion of methotrexate.
#2 Ectopic Pregnancy: Practice Essentials, Background, Etiology
https://emedicine.medscape.com/article/2041923-overview
A meta-analysis that included data from 26 trials demonstrated a success rate of 88.1% with the single-dose methotrexate regimen and a success rate of 92.7% with the multiple-dose regimen. […] Complications of ectopic pregnancy can be secondary to misdiagnosis, late diagnosis, or treatment approach. […] Ectopic pregnancy is the leading cause of maternal death in the first trimester, accounting for 9-13% of all pregnancy-related deaths. […] Virtually all ectopic pregnancies are considered nonviable and are at risk of eventual rupture and resulting hemorrhage. In addition to the immediate morbidity caused by ectopic pregnancy, the woman’s future ability to reproduce may be adversely affected as well. However, patients who are diagnosed with ectopic pregnancy before rupture have a low mortality rate and also have a chance at preserved fertility.
#3 Ectopic Pregnancy – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK539860/
The prognosis for ectopic pregnancy depends on early diagnosis and timely intervention. If identified and treated before rupture, either medically with methotrexate or surgically, the risk of severe complications is significantly reduced. However, delayed diagnosis can lead to tubal rupture, resulting in life-threatening hemorrhage and hemodynamic instability. In such cases, emergency surgical intervention is required, which may involve salpingectomy, potentially impacting future fertility.[4][6] […] Patients with a history of ectopic pregnancy are at increased risk for recurrence, particularly if underlying risk factors such as prior tubal surgery, pelvic inflammatory disease, or assisted reproductive technology are present. Overall, with appropriate management, most patients recover well, but long-term follow-up is important to address fertility concerns and monitor for potential recurrence.[1][15]
#4 Ectopic Pregnancy – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK539860/
The prognosis for ectopic pregnancy depends on early diagnosis and timely intervention. If identified and treated before rupture, either medically with methotrexate or surgically, the risk of severe complications is significantly reduced. However, delayed diagnosis can lead to tubal rupture, resulting in life-threatening hemorrhage and hemodynamic instability. In such cases, emergency surgical intervention is required, which may involve salpingectomy, potentially impacting future fertility.[4][6] […] Patients with a history of ectopic pregnancy are at increased risk for recurrence, particularly if underlying risk factors such as prior tubal surgery, pelvic inflammatory disease, or assisted reproductive technology are present. Overall, with appropriate management, most patients recover well, but long-term follow-up is important to address fertility concerns and monitor for potential recurrence.[1][15]
#5 Ectopic Pregnancy – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK539860/
The prognosis for ectopic pregnancy depends on early diagnosis and timely intervention. If identified and treated before rupture, either medically with methotrexate or surgically, the risk of severe complications is significantly reduced. However, delayed diagnosis can lead to tubal rupture, resulting in life-threatening hemorrhage and hemodynamic instability. In such cases, emergency surgical intervention is required, which may involve salpingectomy, potentially impacting future fertility.[4][6] […] Patients with a history of ectopic pregnancy are at increased risk for recurrence, particularly if underlying risk factors such as prior tubal surgery, pelvic inflammatory disease, or assisted reproductive technology are present. Overall, with appropriate management, most patients recover well, but long-term follow-up is important to address fertility concerns and monitor for potential recurrence.[1][15]
#6 Ectopic pregnancy – UF Health
https://ufhealth.org/conditions-and-treatments/ectopic-pregnancy
If diagnosed early, treatment is very effective. It’s important to seek early care whenever you believe you may be pregnant so your provider may determine the location of the pregnancy. […] One out of three women who have had one ectopic pregnancy can have a baby in the future. Another ectopic pregnancy is more likely to occur. Some women do not become pregnant again. […] The likelihood of a successful pregnancy after an ectopic pregnancy depends on: The woman’s age, Whether she has already had children, Why the first ectopic pregnancy occurred, The health of her fallopian tubes.
#7
https://pmc.ncbi.nlm.nih.gov/articles/PMC10071153/
The current diagnostic standard for EP is a combination of US imaging and serum levels of -hCG. […] Additional serum markers outside of -hCG are being investigated to confirm diagnosis when US results are inconclusive. […] While not widely used in clinical practice, these experimental markers, specifically activin-AB and PAPP-A, show promise for EP diagnosis. […] Future fertility is an important factor to consider during the treatment of EP. Studies, such as the DEMETER trial, have shown no significant difference in fertility rates following medical treatment and conservative surgery. […] The ESEP study also showed that salpingotomy and salpingectomy do not significantly affect future pregnancy outcomes. […] Psychological management is a crucial factor in successful outcomes following EP diagnosis and treatment.
#8
https://pmc.ncbi.nlm.nih.gov/articles/PMC10071153/
The current diagnostic standard for EP is a combination of US imaging and serum levels of -hCG. […] Additional serum markers outside of -hCG are being investigated to confirm diagnosis when US results are inconclusive. […] While not widely used in clinical practice, these experimental markers, specifically activin-AB and PAPP-A, show promise for EP diagnosis. […] Future fertility is an important factor to consider during the treatment of EP. Studies, such as the DEMETER trial, have shown no significant difference in fertility rates following medical treatment and conservative surgery. […] The ESEP study also showed that salpingotomy and salpingectomy do not significantly affect future pregnancy outcomes. […] Psychological management is a crucial factor in successful outcomes following EP diagnosis and treatment.
#9 Ectopic pregnancy – UF Health
https://ufhealth.org/conditions-and-treatments/ectopic-pregnancy
If diagnosed early, treatment is very effective. It’s important to seek early care whenever you believe you may be pregnant so your provider may determine the location of the pregnancy. […] One out of three women who have had one ectopic pregnancy can have a baby in the future. Another ectopic pregnancy is more likely to occur. Some women do not become pregnant again. […] The likelihood of a successful pregnancy after an ectopic pregnancy depends on: The woman’s age, Whether she has already had children, Why the first ectopic pregnancy occurred, The health of her fallopian tubes.
#10 Ectopic Pregnancy: Practice Essentials, Background, Etiology
https://emedicine.medscape.com/article/2041923-overview
However, despite the risk of persistent ectopic pregnancy, some studies have shown salpingostomy to improve reproductive outcome in patients with contralateral tubal damage. […] The modern pelvic surgeon has been led to believe that the treatment of choice for unruptured ectopic pregnancy is salpingostomy, sparing the affected fallopian tube and thereby improving future reproductive outcome. […] Previous history of infertility has been found to be the most significant factor affecting postsurgical fertility. […] The success rates after methotrexate are comparable with laparoscopic salpingostomy, assuming that the previously mentioned selection criteria are observed. […] The average success rates using the multiple-dosage regimen are in the range of 91-95%, as demonstrated by multiple investigators.
#11 Ectopic Pregnancy: Practice Essentials, Background, Etiology
https://emedicine.medscape.com/article/2041923-overview
However, despite the risk of persistent ectopic pregnancy, some studies have shown salpingostomy to improve reproductive outcome in patients with contralateral tubal damage. […] The modern pelvic surgeon has been led to believe that the treatment of choice for unruptured ectopic pregnancy is salpingostomy, sparing the affected fallopian tube and thereby improving future reproductive outcome. […] Previous history of infertility has been found to be the most significant factor affecting postsurgical fertility. […] The success rates after methotrexate are comparable with laparoscopic salpingostomy, assuming that the previously mentioned selection criteria are observed. […] The average success rates using the multiple-dosage regimen are in the range of 91-95%, as demonstrated by multiple investigators.
#12 Ectopic Pregnancy: Practice Essentials, Background, Etiology
https://emedicine.medscape.com/article/2041923-overview
Ectopic pregnancy presents a major health problem for women of childbearing age. It is the result of a flaw in human reproductive physiology that allows the conceptus to implant and mature outside the endometrial cavity, which ultimately ends in the death of the fetus. Without timely diagnosis and treatment, ectopic pregnancy can become a life-threatening situation. […] The evidence in the literature reporting on the treatment of ectopic pregnancy with subsequent reproductive outcome is limited mostly to observational data and a few randomized trials comparing treatment options. […] Assessment of successful treatment and future reproductive outcome with various treatment options is often skewed by selection bias. […] Data in the literature have failed to demonstrate substantial and consistent benefit from either salpingostomy or salpingectomy with regard to improving future reproductive outcome.
#13 Ectopic Pregnancy: Practice Essentials, Background, Etiology
https://emedicine.medscape.com/article/2041923-overview
However, despite the risk of persistent ectopic pregnancy, some studies have shown salpingostomy to improve reproductive outcome in patients with contralateral tubal damage. […] The modern pelvic surgeon has been led to believe that the treatment of choice for unruptured ectopic pregnancy is salpingostomy, sparing the affected fallopian tube and thereby improving future reproductive outcome. […] Previous history of infertility has been found to be the most significant factor affecting postsurgical fertility. […] The success rates after methotrexate are comparable with laparoscopic salpingostomy, assuming that the previously mentioned selection criteria are observed. […] The average success rates using the multiple-dosage regimen are in the range of 91-95%, as demonstrated by multiple investigators.
#14 Ectopic Pregnancy: Practice Essentials, Background, Etiology
https://emedicine.medscape.com/article/2041923-overview
However, despite the risk of persistent ectopic pregnancy, some studies have shown salpingostomy to improve reproductive outcome in patients with contralateral tubal damage. […] The modern pelvic surgeon has been led to believe that the treatment of choice for unruptured ectopic pregnancy is salpingostomy, sparing the affected fallopian tube and thereby improving future reproductive outcome. […] Previous history of infertility has been found to be the most significant factor affecting postsurgical fertility. […] The success rates after methotrexate are comparable with laparoscopic salpingostomy, assuming that the previously mentioned selection criteria are observed. […] The average success rates using the multiple-dosage regimen are in the range of 91-95%, as demonstrated by multiple investigators.
#15 Ectopic Pregnancy: Practice Essentials, Background, Etiology
https://emedicine.medscape.com/article/2041923-overview
However, despite the risk of persistent ectopic pregnancy, some studies have shown salpingostomy to improve reproductive outcome in patients with contralateral tubal damage. […] The modern pelvic surgeon has been led to believe that the treatment of choice for unruptured ectopic pregnancy is salpingostomy, sparing the affected fallopian tube and thereby improving future reproductive outcome. […] Previous history of infertility has been found to be the most significant factor affecting postsurgical fertility. […] The success rates after methotrexate are comparable with laparoscopic salpingostomy, assuming that the previously mentioned selection criteria are observed. […] The average success rates using the multiple-dosage regimen are in the range of 91-95%, as demonstrated by multiple investigators.
#16 Ectopic Pregnancy: Practice Essentials, Background, Etiology
https://emedicine.medscape.com/article/2041923-overview
A meta-analysis that included data from 26 trials demonstrated a success rate of 88.1% with the single-dose methotrexate regimen and a success rate of 92.7% with the multiple-dose regimen. […] Complications of ectopic pregnancy can be secondary to misdiagnosis, late diagnosis, or treatment approach. […] Ectopic pregnancy is the leading cause of maternal death in the first trimester, accounting for 9-13% of all pregnancy-related deaths. […] Virtually all ectopic pregnancies are considered nonviable and are at risk of eventual rupture and resulting hemorrhage. In addition to the immediate morbidity caused by ectopic pregnancy, the woman’s future ability to reproduce may be adversely affected as well. However, patients who are diagnosed with ectopic pregnancy before rupture have a low mortality rate and also have a chance at preserved fertility.
#17 Time to resolution of tubal ectopic pregnancy following methotrexate treatment: A retrospective cohort study | PLOS One
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0268741
The median time to resolution for ectopic pregnancies treated with methotrexate is 22 days and associated with baseline hCG levels. The predictive value of baseline hCG may be useful in clinical decision making and counselling women considering methotrexate for ectopic pregnancy. […] Time to resolution was longer when the baseline hCG concentrations was above 2000 IU/L and early trends in hCG were predictive of time to resolution and treatment success. […] We found that baseline hCG levels were associated with time to resolution, with an increase from 20 days when baseline hCG levels were 1000 IU/L to 34.5 days for levels 2000-2999 IU/L. […] A large rise in hCG by day 4 of up to 999 IU/L was associated with a significant increase in the time to resolution (21 vs 61 days) and the likelihood of requiring rescue surgery (odds ratio 28.6). […] These findings are of clinical importance and may be useful in guiding treatment decisions and setting patient expectations for likely resolution times and duration of required follow up.
#18 Time to resolution of tubal ectopic pregnancy following methotrexate treatment: A retrospective cohort study | PLOS One
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0268741
The median time to resolution for ectopic pregnancies treated with methotrexate is 22 days and associated with baseline hCG levels. The predictive value of baseline hCG may be useful in clinical decision making and counselling women considering methotrexate for ectopic pregnancy. […] Time to resolution was longer when the baseline hCG concentrations was above 2000 IU/L and early trends in hCG were predictive of time to resolution and treatment success. […] We found that baseline hCG levels were associated with time to resolution, with an increase from 20 days when baseline hCG levels were 1000 IU/L to 34.5 days for levels 2000-2999 IU/L. […] A large rise in hCG by day 4 of up to 999 IU/L was associated with a significant increase in the time to resolution (21 vs 61 days) and the likelihood of requiring rescue surgery (odds ratio 28.6). […] These findings are of clinical importance and may be useful in guiding treatment decisions and setting patient expectations for likely resolution times and duration of required follow up.
#19 Time to resolution of tubal ectopic pregnancy following methotrexate treatment: A retrospective cohort study | PLOS One
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0268741
The median time to resolution for ectopic pregnancies treated with methotrexate is 22 days and associated with baseline hCG levels. The predictive value of baseline hCG may be useful in clinical decision making and counselling women considering methotrexate for ectopic pregnancy. […] Time to resolution was longer when the baseline hCG concentrations was above 2000 IU/L and early trends in hCG were predictive of time to resolution and treatment success. […] We found that baseline hCG levels were associated with time to resolution, with an increase from 20 days when baseline hCG levels were 1000 IU/L to 34.5 days for levels 2000-2999 IU/L. […] A large rise in hCG by day 4 of up to 999 IU/L was associated with a significant increase in the time to resolution (21 vs 61 days) and the likelihood of requiring rescue surgery (odds ratio 28.6). […] These findings are of clinical importance and may be useful in guiding treatment decisions and setting patient expectations for likely resolution times and duration of required follow up.
#20 Time to resolution of tubal ectopic pregnancy following methotrexate treatment: A retrospective cohort study | PLOS One
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0268741
The median time to resolution for ectopic pregnancies treated with methotrexate is 22 days and associated with baseline hCG levels. The predictive value of baseline hCG may be useful in clinical decision making and counselling women considering methotrexate for ectopic pregnancy. […] Time to resolution was longer when the baseline hCG concentrations was above 2000 IU/L and early trends in hCG were predictive of time to resolution and treatment success. […] We found that baseline hCG levels were associated with time to resolution, with an increase from 20 days when baseline hCG levels were 1000 IU/L to 34.5 days for levels 2000-2999 IU/L. […] A large rise in hCG by day 4 of up to 999 IU/L was associated with a significant increase in the time to resolution (21 vs 61 days) and the likelihood of requiring rescue surgery (odds ratio 28.6). […] These findings are of clinical importance and may be useful in guiding treatment decisions and setting patient expectations for likely resolution times and duration of required follow up.
#21 Using a decline in serum hCG between days 0â4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study | BMC Pregnancy and Childbirth | Full Text
https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-13-30
The current measure of treatment efficacy of single-dose methotrexate for ectopic pregnancy, is a fall in serum hCG of 15% between days 4-7 of treatment, which has a positive predictive value of 93% for treatment success. […] Two small studies have proposed a fall in serum hCG between days 0-4 after treatment confers similar, earlier prognostic information, with positive predictive values of 100% and 88% for treatment success. […] We have verified that a decline in serum hCG between days 0-4 after methotrexate treatment for ectopic pregnancies, with pre-treatment serum hCG levels 3000 IU/L, provides an early indication of likelihood of treatment success, and performs just as well as the existing measure, which only provides prognostic information on day 7. […] The fact that serum hCG trends may be able to accurately predict treatment outcomes for many women as early as day 4 has potentially important clinical implications.
#22 Using a decline in serum hCG between days 0â4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study | BMC Pregnancy and Childbirth | Full Text
https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-13-30
The current measure of treatment efficacy of single-dose methotrexate for ectopic pregnancy, is a fall in serum hCG of 15% between days 4-7 of treatment, which has a positive predictive value of 93% for treatment success. […] Two small studies have proposed a fall in serum hCG between days 0-4 after treatment confers similar, earlier prognostic information, with positive predictive values of 100% and 88% for treatment success. […] We have verified that a decline in serum hCG between days 0-4 after methotrexate treatment for ectopic pregnancies, with pre-treatment serum hCG levels 3000 IU/L, provides an early indication of likelihood of treatment success, and performs just as well as the existing measure, which only provides prognostic information on day 7. […] The fact that serum hCG trends may be able to accurately predict treatment outcomes for many women as early as day 4 has potentially important clinical implications.
#23 Using a decline in serum hCG between days 0â4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study | BMC Pregnancy and Childbirth | Full Text
https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-13-30
The current measure of treatment efficacy of single-dose methotrexate for ectopic pregnancy, is a fall in serum hCG of 15% between days 4-7 of treatment, which has a positive predictive value of 93% for treatment success. […] Two small studies have proposed a fall in serum hCG between days 0-4 after treatment confers similar, earlier prognostic information, with positive predictive values of 100% and 88% for treatment success. […] We have verified that a decline in serum hCG between days 0-4 after methotrexate treatment for ectopic pregnancies, with pre-treatment serum hCG levels 3000 IU/L, provides an early indication of likelihood of treatment success, and performs just as well as the existing measure, which only provides prognostic information on day 7. […] The fact that serum hCG trends may be able to accurately predict treatment outcomes for many women as early as day 4 has potentially important clinical implications.
#24 Using a decline in serum hCG between days 0â4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study | BMC Pregnancy and Childbirth | Full Text
https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/1471-2393-13-30
This study shows that a fall in serum hCG between days 0-4 of treatment represents an 85% likelihood of treatment success with no further intervention, medical or surgical, for single-dose methotrexate treatment of ectopic pregnancy. […] We have found that a fall in serum hCG between days 0-4 after single-dose methotrexate treatment of ectopic pregnancy (where the pre-treatment serum hCG is 3000 IU/L), predicts treatment success in 85% of cases, with no further intervention required (medical or surgical).
#25 (PDF) Prediction of ectopic pregnancy in women with a pregnancy of unknown location
https://www.academia.edu/24219170/Prediction_of_ectopic_pregnancy_in_women_with_a_pregnancy_of_unknown_location
The hCG ratio seems to be an optimal test for the prediction of pregnancy failure in a PUL population. […] The most important variable for predicting the likelihood of successful non-surgical management was the pre-treatment hCG ratio. […] The hCG ratio may be preferred to single measurements of progesterone to predict the viability of IPUVs in the PUL population.
#26 (PDF) Prediction of ectopic pregnancy in women with a pregnancy of unknown location
https://www.academia.edu/24219170/Prediction_of_ectopic_pregnancy_in_women_with_a_pregnancy_of_unknown_location
The hCG ratio seems to be an optimal test for the prediction of pregnancy failure in a PUL population. […] The most important variable for predicting the likelihood of successful non-surgical management was the pre-treatment hCG ratio. […] The hCG ratio may be preferred to single measurements of progesterone to predict the viability of IPUVs in the PUL population.
#27 (PDF) Prediction of ectopic pregnancy in women with a pregnancy of unknown location
https://www.academia.edu/24219170/Prediction_of_ectopic_pregnancy_in_women_with_a_pregnancy_of_unknown_location
K E Y W O R D S: ectopic pregnancy; human chorionic gonadotropin ratio; logistic regression; pregnancy of unknown location; quadratic effect […] The aim of this study was to improve on the performance of this model for the detection of developing ectopic pregnancies in women with pregnancies of unknown location (PULs). […] In the prediction of ectopic pregnancy, M4 gave an area under the ROC curve (AUC) of 0.900 and M1 gave an AUC of 0.842 (P = 0.0303). […] Although Model M4 is superior to Model M1 when comparing the AUCs for prediction of developing ectopic pregnancies in a PUL population, in real terms this model did not result in substantially more pregnancies being classified correctly as developing ectopic pregnancies. […] This logistic regression model, based on the hCG ratio, can be used to predict the outcome of PULs, especially the ectopic pregnancies, with a high degree of certainty.
#28 (PDF) Prediction of ectopic pregnancy in women with a pregnancy of unknown location
https://www.academia.edu/24219170/Prediction_of_ectopic_pregnancy_in_women_with_a_pregnancy_of_unknown_location
The hCG ratio seems to be an optimal test for the prediction of pregnancy failure in a PUL population. […] The most important variable for predicting the likelihood of successful non-surgical management was the pre-treatment hCG ratio. […] The hCG ratio may be preferred to single measurements of progesterone to predict the viability of IPUVs in the PUL population.
#29 Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies | The BMJ
https://www.bmj.com/content/345/bmj.e6077
Objective To determine the accuracy with which a single progesterone measurement in early pregnancy discriminates between viable and non-viable pregnancy. […] A single progesterone measurement for women in early pregnancy presenting with bleeding or pain and inconclusive ultrasound assessments can rule out a viable pregnancy. […] The meta-analysis shows that a single progesterone measurement is useful in predicting non-viable pregnancies in women with pain or bleeding when an ultrasound investigation proves to be inconclusive. A low concentration of progesterone (less than 3.2 to 6 ng/mL) in these women ruled out a viable pregnancy in 99.2% of women. However, the test cannot distinguish women with an ectopic pregnancy from those with an early normal pregnancy or a miscarriage and should not be used for this purpose.
#30 Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies | The BMJ
https://www.bmj.com/content/345/bmj.e6077
Objective To determine the accuracy with which a single progesterone measurement in early pregnancy discriminates between viable and non-viable pregnancy. […] A single progesterone measurement for women in early pregnancy presenting with bleeding or pain and inconclusive ultrasound assessments can rule out a viable pregnancy. […] The meta-analysis shows that a single progesterone measurement is useful in predicting non-viable pregnancies in women with pain or bleeding when an ultrasound investigation proves to be inconclusive. A low concentration of progesterone (less than 3.2 to 6 ng/mL) in these women ruled out a viable pregnancy in 99.2% of women. However, the test cannot distinguish women with an ectopic pregnancy from those with an early normal pregnancy or a miscarriage and should not be used for this purpose.
#31 Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies | The BMJ
https://www.bmj.com/content/345/bmj.e6077
The existing evidence shows that specificity is higher (98.4%) and sensitivity lower (74.6%) using a cut-off value around 5 ng/mL. […] This test could be added to the existing algorithms for evaluation of early pregnancy, and its effect should be evaluated through a randomised trial comparing algorithms with and without serum progesterone. […] In conclusion, this meta-analysis found that a single progesterone measurement for women in early pregnancy presenting with bleeding or pain and inconclusive ultrasound assessments can rule out a viable pregnancy.
#32 Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies | The BMJ
https://www.bmj.com/content/345/bmj.e6077
The existing evidence shows that specificity is higher (98.4%) and sensitivity lower (74.6%) using a cut-off value around 5 ng/mL. […] This test could be added to the existing algorithms for evaluation of early pregnancy, and its effect should be evaluated through a randomised trial comparing algorithms with and without serum progesterone. […] In conclusion, this meta-analysis found that a single progesterone measurement for women in early pregnancy presenting with bleeding or pain and inconclusive ultrasound assessments can rule out a viable pregnancy.
#33
https://pmc.ncbi.nlm.nih.gov/articles/PMC10071153/
The current diagnostic standard for EP is a combination of US imaging and serum levels of -hCG. […] Additional serum markers outside of -hCG are being investigated to confirm diagnosis when US results are inconclusive. […] While not widely used in clinical practice, these experimental markers, specifically activin-AB and PAPP-A, show promise for EP diagnosis. […] Future fertility is an important factor to consider during the treatment of EP. Studies, such as the DEMETER trial, have shown no significant difference in fertility rates following medical treatment and conservative surgery. […] The ESEP study also showed that salpingotomy and salpingectomy do not significantly affect future pregnancy outcomes. […] Psychological management is a crucial factor in successful outcomes following EP diagnosis and treatment.
#34 Ectopic Pregnancy – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK539860/
The prognosis for ectopic pregnancy depends on early diagnosis and timely intervention. If identified and treated before rupture, either medically with methotrexate or surgically, the risk of severe complications is significantly reduced. However, delayed diagnosis can lead to tubal rupture, resulting in life-threatening hemorrhage and hemodynamic instability. In such cases, emergency surgical intervention is required, which may involve salpingectomy, potentially impacting future fertility.[4][6] […] Patients with a history of ectopic pregnancy are at increased risk for recurrence, particularly if underlying risk factors such as prior tubal surgery, pelvic inflammatory disease, or assisted reproductive technology are present. Overall, with appropriate management, most patients recover well, but long-term follow-up is important to address fertility concerns and monitor for potential recurrence.[1][15]
#35 Ectopic pregnancy – UF Health
https://ufhealth.org/conditions-and-treatments/ectopic-pregnancy
If diagnosed early, treatment is very effective. It’s important to seek early care whenever you believe you may be pregnant so your provider may determine the location of the pregnancy. […] One out of three women who have had one ectopic pregnancy can have a baby in the future. Another ectopic pregnancy is more likely to occur. Some women do not become pregnant again. […] The likelihood of a successful pregnancy after an ectopic pregnancy depends on: The woman’s age, Whether she has already had children, Why the first ectopic pregnancy occurred, The health of her fallopian tubes.
#36
https://pmc.ncbi.nlm.nih.gov/articles/PMC10071153/
Ectopic pregnancies are the leading cause of maternal mortality in the first trimester, with an incidence of 5%10% of all pregnancy-related deaths. […] Ectopic pregnancy (EP) ruptures are the leading cause of maternal mortality within the first trimester of pregnancy with a rate of 9%14% and an incidence of 5%10% of all pregnancy-related deaths. […] The current standard for diagnostics includes ultrasound (US) imagingtransvaginal (TVUS) or transabdominal (TAUS)and -human chorionic gonadotropin (-hCG) level monitoring. Earlier and more specific EP diagnosis can help reduce maternal mortality rates. […] Once an EP is diagnosed, treatment can consist of medical, surgical, or expectant management, with innovative emphasis on conservation of fertility. […] Current innovations in ectopic pregnancy management aim to preserve fertility and include laparoscopic partial tubal resection with end-to-end anastomosis and uterine artery embolization with intrauterine infusion of methotrexate.
#37 Ectopic Pregnancy: Practice Essentials, Background, Etiology
https://emedicine.medscape.com/article/2041923-overview
A meta-analysis that included data from 26 trials demonstrated a success rate of 88.1% with the single-dose methotrexate regimen and a success rate of 92.7% with the multiple-dose regimen. […] Complications of ectopic pregnancy can be secondary to misdiagnosis, late diagnosis, or treatment approach. […] Ectopic pregnancy is the leading cause of maternal death in the first trimester, accounting for 9-13% of all pregnancy-related deaths. […] Virtually all ectopic pregnancies are considered nonviable and are at risk of eventual rupture and resulting hemorrhage. In addition to the immediate morbidity caused by ectopic pregnancy, the woman’s future ability to reproduce may be adversely affected as well. However, patients who are diagnosed with ectopic pregnancy before rupture have a low mortality rate and also have a chance at preserved fertility.